ANG Lifesciences India Ltd

Fri 18/09/2026,16:1:0 | BSE : ANG

₹37.970.74 (1.99%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 37.23

Previous Close

₹ 37.23

Volume

8283

Mkt Cap ( ₹ Cr)

₹ 49.58

High

₹ 37.97

Low

₹ 37.23

52 Week High

₹ 49.69

52 Week Low

₹ 17.63

Book Value Per Share

₹ 37.25

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on ANG Lifesciences India Ltd

Your Vote -

Buy

60.00%

Hold

0.00%

Sell

40.00%

60.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts ANG Lifesciences India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • ANG Lifesciences Ind has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    15 Sep 2026, 7:00AM As of June 2026, 70.60% is owned by Indian Promoters and 29.40% by Public. <p align=justify> Top two Promoters holding highest number of shares of ANG
  • ANG Lifesciences Ind - Reg. 34 (1) Annual Report.

    7 Sep 2026, 10:57PM Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('' Listing Regulations''), please find attached herewith the Annua
  • ANG Lifesciences Ind - Notice Of 20Th AGM Of The Company On Wednesday, 30Th September, 2026 At 12 :00 Noon. (IST) Through Vid

    7 Sep 2026, 8:49PM Notice of 20th AGM
  • ANG Lifesciences Ind - Intimation Of Book Closure

    7 Sep 2026, 8:39PM Intimation of Book Closure
  • ANG Lifesciences Ind - Intimation Of 20Th Annual General Meeting

    7 Sep 2026, 8:33PM Intimation of 20th Annual General Meeting
  • ANG Lifesciences Ind - Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Intimation Of AGM

    7 Sep 2026, 8:27PM This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regula
  • ANG Lifesciences Ind - Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2

    14 Aug 2026, 6:31PM Financial Results 30.06.2026.
  • ANG Lifesciences Ind - Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudite

    14 Aug 2026, 6:25PM Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regul
  • ANG Lifesciences Ind - Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financi

    7 Aug 2026, 12:39PM ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consid
  • ANG Lifesciences Ind - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    21 Jul 2026, 4:58PM Reg 74(5) Certificate

Key fundamentals

Evaluate the intrinsic value of ANG Lifesciences India Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 127.1866 134.6123 132.8395 138.2846 144.4747
Liabilities 127.1866 134.6123 132.8395 138.2846 144.4747
Equity 13.0583 13.0583 13.0583 13.0583 10.3666
Gross Profit 6.6127 -1.8075 9.1151 11.0674 65.0824
Net Profit -4.7264 -10.3429 -8.6481 -0.6622 39.713
Cash From Operating Activities 13.7188 -2.2927 -13.1316 26.0123 27.3877
NPM(%) -5.15 -11.5 -6.58 -0.31 11.38
Revenue 91.6045 89.9101 131.3688 207.0055 348.6694
Expenses 84.9918 91.7176 122.2537 195.9381 283.587
ROE(%) -9.71 -21.26 -17.77 -1.36 81.63

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to ANG Lifesciences India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 797.00 -5.93 21.12 21.25 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 116.00 2.97 1610.00 77.42 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 14.20 0.28 0.00 160.76 -39.50 0.00
Astec Lifesciences Ltd 713.25 -1.96 0.00 82.96 -363.14 0.00

Company Info

The Company was originally incorporated as ANG Lifesciences India Private Limited on June 14, 2006 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh as a private limited Company under the Companies Act, 1956. On conversion into public limited Company the name of the Company was changed to ANG Lifesciences India Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on January 18, 2010 and a fresh certificate of incorporation dated March 02, 2010 issued by the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. the company was further converted into private limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on August 31, 2010 and a fresh certificate of incorporation was issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh dated September 22, 2010. Subsequently, on conversion into public limited Company the name of the company again changed to ANG Lifesciences India Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on May 04, 2016 and a fresh certificate of incorporation dated May 18, 2016 issued by the Registrar of Companies, Chandigarh. Major Events and Milestones The table below sets forth the key events in the history of the Company: 2006-07 -Incorporation of the Company on June 14, 2006 2008-09 -Commenced commercial production of the Company 2012-13 -Robust jump in the turnover of the Company by 140% as compared to previous year 2013-14 -Commenced the export sales , Government supplies and turnover increased by 112% as compared to previous year 2014-15 -Commenced direct sale of medicines in PAN India covering hospitals , Doctors through stockists 2015-16 -Company certified with WHO and GMP norms and continued to growth in the turnover 2021 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 1:4.

The Company was originally incorporated as ANG Lifesciences India Private Limited on June 14, 2006 with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh as a private limited Company under the Companies Act, 1956. On conversion into public limited Company the name of the Company was changed to ANG Lifesciences India Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on January 18, 2010 and a fresh certificate of incorporation dated March 02, 2010 issued by the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. the company was further converted into private limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on August 31, 2010 and a fresh certificate of incorporation was issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh dated September 22, 2010. Subsequently, on conversion into public limited Company the name of the company again changed to ANG Lifesciences India Limited pursuant to special resolution passed at the Extra Ordinary General Meeting held on May 04, 2016 and a fresh certificate of incorporation dated May 18, 2016 issued by the Registrar of Companies, Chandigarh. Major Events and Milestones The table below sets forth the key events in the history of the Company: 2006-07 -Incorporation of the Company on June 14, 2006 2008-09 -Commenced commercial production of the Company 2012-13 -Robust jump in the turnover of the Company by 140% as compared to previous year 2013-14 -Commenced the export sales , Government supplies and turnover increased by 112% as compared to previous year 2014-15 -Commenced direct sale of medicines in PAN India covering hospitals , Doctors through stockists 2015-16 -Company certified with WHO and GMP norms and continued to growth in the turnover 2021 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 1:4.

Parent Organisation

ANG Lifesciences India Ltd.

Founded

14/06/2006

Managing Director

Mr.Rajesh Gupta

NSE Symbol

FAQ